Monash IVF says it has mistakenly transferred the wrong embryo to a patient in a Melbourne laboratory, the second time in two months that the ASX-listed fertility services has admitted to the same error.
Monash IVF shares slumped more than 17 per cent on Tuesday after the company disclosed the issue, taking their slide to almost 50 per cent since the original incident was made public in early April.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.